Literature DB >> 22189136

Discovery of potent, selective and orally bioavailable triaryl-sulfonamide based PTP1B inhibitors.

Dipam Patel1, Mukul Jain, Shailesh R Shah, Rajesh Bahekar, Pradip Jadav, Amit Joharapurkar, Nirav Dhanesha, Mubeen Shaikh, Kalapatapu V V M Sairam, Prashant Kapadnis.   

Abstract

A novel series of pTyr mimetics containing triaryl-sulfonamide derivatives (5a-r) are reported as potent and selective PTP1B inhibitors. Some of the test compounds (5o and 5p) showed excellent selectivity towards PTP1B over various PTPs, including TCPTP (in vitro). The lead compound 5o showed potent antidiabetic activity (in vivo), along with improved pharmacokinetic profile. These preliminary results confirm discovery of highly potent and selective PTP1B inhibitors for the treatment of T2DM.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22189136     DOI: 10.1016/j.bmcl.2011.11.122

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

Review 1.  Phosphotyrosine isosteres: past, present and future.

Authors:  Robert A Cerulli; Joshua A Kritzer
Journal:  Org Biomol Chem       Date:  2019-11-28       Impact factor: 3.876

2.  New Frontiers in Druggability.

Authors:  Dima Kozakov; David R Hall; Raeanne L Napoleon; Christine Yueh; Adrian Whitty; Sandor Vajda
Journal:  J Med Chem       Date:  2015-08-11       Impact factor: 7.446

3.  Investigating the impact of Asp181 point mutations on interactions between PTP1B and phosphotyrosine substrate.

Authors:  Mengyuan Liu; Lushan Wang; Xun Sun; Xian Zhao
Journal:  Sci Rep       Date:  2014-05-28       Impact factor: 4.379

4.  HPN, a synthetic analogue of bromophenol from red alga Rhodomela confervoides: synthesis and anti-diabetic effects in C57BL/KsJ-db/db mice.

Authors:  Dayong Shi; Shuju Guo; Bo Jiang; Chao Guo; Tao Wang; Luyong Zhang; Jingya Li
Journal:  Mar Drugs       Date:  2013-01-30       Impact factor: 5.118

5.  Wushenziye Formula Improves Skeletal Muscle Insulin Resistance in Type 2 Diabetes Mellitus via PTP1B-IRS1-Akt-GLUT4 Signaling Pathway.

Authors:  Chunyu Tian; Hong Chang; Xiaojin La; Ji-An Li
Journal:  Evid Based Complement Alternat Med       Date:  2017-12-31       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.